Chemours (CC) Tops Q3 EPS by 14c

Chemours (NYSE: CC) reported Q3 EPS of $0.47, $0.14 better than the analyst estimate of $0.33. Revenue for the quarter came in at $1.23 billion versus the consensus estimate of $1.2 billion.

Outlook:

Mr. Vergnano concluded: "I am proud of the resilience our business has shown over the first three quarters of 2020. Our results are a testament to the hard work of the people of Chemours, our dedication to the success of our customers, and our ability to execute in the face of uncertainty. Looking ahead, I am confident that we are well positioned to create sustained value through the economic recovery and remain committed to achieving our full potential as Chemours."

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• Hasbro (HAS) brand strength sees earnings top expectations
• Boston Scientific (BSX) pipeline strength fuels quarterly earnings beat